Not 60,000 it was 650, 000 back in 2019. Or were you reffering to some other purchase. At the time this was a fairly significant purchase on market and what caught my interest before I bought in. Very clever it appears as price at the time was 16c ish. At that point it was still completely untested in humans.
SYDNEY, Australia, 7 March 2019: Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing a new class of synthetic antibiotics, is pleased to advise that Executive Director, James Graham, has purchased 650,000 fully paid ordinary shares in the Company on the market for a total consideration of approximately $100,460 (an average price of $0.1546 per share).
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)